Enhanced delivery system of flutamide loaded chitosan-dextran sulphate nanoparticles for prostate cancer

Anitha, A., Uthaman, Saji, Nair, Shantikumar V., Jayakumar, R and Lakshmanan, Vinoth-Kumar (2013) Enhanced delivery system of flutamide loaded chitosan-dextran sulphate nanoparticles for prostate cancer. Journal of Biomedical Nanotechnology, 9 3: 335-347. doi:10.1166/jbn.2013.1558


Author Anitha, A.
Uthaman, Saji
Nair, Shantikumar V.
Jayakumar, R
Lakshmanan, Vinoth-Kumar
Title Enhanced delivery system of flutamide loaded chitosan-dextran sulphate nanoparticles for prostate cancer
Journal name Journal of Biomedical Nanotechnology   Check publisher's open access policy
ISSN 1550-7033
1550-7041
Publication date 2013-03-01
Year available 2013
Sub-type Article (original research)
DOI 10.1166/jbn.2013.1558
Open Access Status Not Open Access
Volume 9
Issue 3
Start page 335
End page 347
Total pages 13
Place of publication Valencia, CA, United States
Publisher American Scientific Publishers
Language eng
Abstract In the current work, a sustained drug delivery system of flutamide (FLT) was developed using chitosan (CS) and dextran sulphate (DS) nanoparticles and were characterized using different techniques. The prepared nanoparticles showed a size of 80–120 nm with an entrapment efficiency of 55 ± 6.95%. In addition, blood compatibility, in vitro cytotoxicity, drug release and cellular uptake studies were also carried out. The drug release studies showed a sustained and pH dependent release pattern as a result, after 120 h about 66% drug release occurred at pH 7.4 and 78% release occurred in acidic pH. MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and LDH (lactate dehydrogenase) experiments proved the preferential toxicity of drug loaded nanoparticles towards prostate cancer cells (PC3) unlike in normal cells, mouse fibroblast cells (L929). The cell death mechanism of drug loaded nanoparticles for a concentration of 50 and 75 nM showed 28 ± 2 and 35.2 ± 4% apoptosis in samples treated with the PC3 cells after 24 h. Fluorescent microscopic imaging and flow cytometry confirmed the preferential uptake of the nanoparticles (NPs) in the prostate cancer cells (PC3) unlike in normal (L929) cells. Hence the developed FLT loaded CS-DS NPs could be used as a promising system for controlled delivery in prostate cancer.
Keyword Prostate caner
Anti-Aandrogen
Flutamide
Chitosan
Dextran sulphate
Nanoparticles (NPs)
Cancer drug delivery
Q-Index Code C1
Q-Index Status Provisional Code
Grant ID SR/NM/NS-99/2009
9/963 (0005) 2K10378-EMR-I
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Chemistry and Molecular Biosciences
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 16 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 17 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Thu, 12 Feb 2015, 21:43:46 EST by Anitha Sudheesh Kumar on behalf of School of Chemistry & Molecular Biosciences